DUAKLIR PRESSAIR
LOE Approachingaclidinium bromide and formoterol fumarate
NDAINHALATIONPOWDER, METERED
Approved
Mar 2019
Lifecycle
LOE Approaching
Competitive Pressure
15/100
Clinical Trials
2
Data completeness
7/8 — Comprehensive
DUAKLIR PRESSAIR (aclidinium bromide and formoterol fumarate) is bronchodilators: aclidinium a long-acting muscarinic antagonist (also known as an anticholinergic) and formoterol a long-acting beta 2 -adrenergic agonist. Approved for chronic obstructive pulmonary disease, copd, asthma. First approved in 2019.
Drug data last refreshed 4d ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
DUAKLIR PRESSAIR is a dual-action inhaled bronchodilator combining aclidinium bromide (long-acting muscarinic antagonist) and formoterol fumarate (long-acting beta-2 agonist) for maintenance treatment of chronic obstructive pulmonary disease (COPD). The fixed-dose combination targets two distinct pathways to relax airway smooth muscle and improve airflow. It is delivered as a metered-dose powder via the PRESSAIR dry-powder inhaler device.
$0.049BPart D
LOE Approaching2.8 years to LOELOE approaching in ~2.9 years signals a transition from growth-focused teams toward lifecycle management and post-LOE defensive positioning strategies.
Mechanism of Action
bronchodilators: aclidinium a long-acting muscarinic antagonist (also known as an anticholinergic) and formoterol a long-acting beta 2 -adrenergic agonist. Further information regarding these two substances is provided below. The mechanism of action described below for the individual components…
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.